• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

2 years ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Elon Musk Reveals Bold Plans for SpaceX's Future

chest

Elon Musk outlines bold plans for SpaceX, including sending thousands to the Moon and launching AI satellites.

user avatarSon Min-ho

Analysts Present Varied Valuation Forecasts for SpaceX by 2036

chest

Analysts present a wide range of forecasts for SpaceX's valuation by 2036, estimating between $470 billion and $40 trillion, influenced by unproven business models and market conditions.

user avatarAyman Ben Youssef

Visa Launches New Platform for Stablecoin Management

chest

Visa has launched the Visa Stablecoin Platform, allowing banks, fintechs, and payment providers to manage stablecoin operations seamlessly.

user avatarTando Nkube

House Financial Hearing in New York Aims to Shape Digital Asset Regulation

chest

A house field hearing in New York aims to build consensus around standard digital asset legislation, impacting market dynamics.

user avatarKofi Adjeman

BNB Maintains 578 Support as Inflation Relief Influences Market

chest

BNB maintains support at 578 as inflation relief influences market dynamics.

user avatarSatoshi Nakamura

Cardano Foundation Takes Over Token2049 Event Organization

chest

The Cardano Foundation has officially taken over the organization of the Token2049 event from EMURGO as of July 15.

user avatarNguyen Van Long

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.